200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 827603-92-9

827603-92-9

827603-92-9 | Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]-N-hydroxy-

CAS No: 827603-92-9 Catalog No: AG004U9U MDL No:

Product Description

Catalog Number:
AG004U9U
Chemical Name:
Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]-N-hydroxy-
CAS Number:
827603-92-9
Molecular Formula:
C15H15NO3S
Molecular Weight:
289.3495
IUPAC Name:
2-benzhydrylsulfinyl-N-hydroxyacetamide
InChI:
InChI=1S/C15H15NO3S/c17-14(16-18)11-20(19)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15,18H,11H2,(H,16,17)
InChI Key:
CGNMLOKEMNBUAI-UHFFFAOYSA-N
SMILES:
ONC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1
EC Number:
264-303-1

Properties

Complexity:
318  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
289.077g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
289.349g/mol
Monoisotopic Mass:
289.077g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
85.6A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6  

Literature

Title Journal
Practical use and risk of modafinil, a novel waking drug. Environmental health and toxicology 20120101
Prevalence of legal and illegal stimulating agents in sports. Analytical and bioanalytical chemistry 20110801
Development of a validated LC method for enantiomeric separation and determination of adrafinil and its related substances on a Chiralcel OJ-H column connected to PDA and polarimetric detectors in series. Biomedical chromatography : BMC 20101101
Epidemiological analysis of doping offences in the professional tennis circuit. Journal of occupational medicine and toxicology (London, England) 20100101
A novel study of screening and confirmation of modafinil, adrafinil and their metabolite modafinilic acid under EI-GC-MS and ESI-LC-MS-MS ionization. Indian journal of pharmacology 20091201
Enantioselective separation and determination of adrafinil and modafinil on Chiralcel OJ-H column in rat serum and urine using solid-phase extraction followed by HPLC. Biomedical chromatography : BMC 20090801
Doping control analysis for adrafinil and its major metabolites in human urine. Rapid communications in mass spectrometry : RCM 20090601
LC-MS of novel narcoepileptics and related substances. Journal of separation science 20090501
Natural non-trasgenic animal models for research in Alzheimer's disease. Current Alzheimer research 20090401
Drug metabolism and pharmacokinetics. Indian journal of pharmacology 20081001
LC-ESI-MS determination and pharmacokinetics of adrafinil in rats. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080915
[Pharmacological approach to desychronization of the sleep-wakefulness cycle in the military and sport environment]. Annales pharmaceutiques francaises 20070701
Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test. Psychopharmacology 20060101
The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Progress in neuro-psychopharmacology & biological psychiatry 20050301
Adrafinil-induced orofacial dyskinesia. Movement disorders : official journal of the Movement Disorder Society 20040801
Adrafinil disrupts performance on a delayed nonmatching-to-position task in aged beagle dogs. Pharmacology, biochemistry, and behavior 20030801
Pharmacological evidence of the stimulation of central alpha-adrenergic receptors. Progress in neuro-psychopharmacology & biological psychiatry 19830101
A possibe alpha-adrenergic mechanism for drug (CRL 40028)-induced hyperactivity. European journal of pharmacology 19791026

Related Products

© 2019 Angene International Limited. All rights Reserved.